期刊文献+

慢血流现象与内皮功能的相关分析 被引量:4

Relationship between slow coronary flow and endothelial disorder
下载PDF
导出
摘要 目的进一步探讨慢血流现象与内皮功能紊乱的相关性。方法112例冠状动脉造影正常患者,用TIMI帧数方法进行慢血流和正常血流分组。对慢血流和正常血流患者性别、年龄、胆固醇、高血压、糖尿病、吸烟、内皮素(ET)-1、一氧化氮(NO)、白介素(IL)-6等因素对比分析。结果慢血流组男性多于女性(30例比6例),吸烟患者多于不吸烟者(22例比14例)。慢血流组ET-1和IL-6水平高于正常血流组(分别为108.42±36.12pg/mL比84.74±39.16pg/mL和158.28±178.86pg/mL比108.07±84.43pg/mL,P均<0.05);慢血流组NO水平低于正常血流组(35.66±12.28μmol/L比42.74±17.51μmol/L,P<0.05)。结论慢血流现象与内皮功能紊乱相关。评价慢血流现象时要考虑影响血流的其他因素。 Objective To study the relationship between slow coronary flow and endothelium disorder. Methods One hundred and twelve patients with normal coronary angiography were divided into the slow flow group (n =38) and the normal flow group (n =84) in terms of their TIMI frame counts. Risk factors including sex, age, cholesterol, hypertension, diabetes, history of smoking and blood levels of endothelium-1, nitric oxide and interleukin-6 were compared between the 2 groups. Results Slow coronary flow was more common in male than in female (45 vs 39). Patients who smoked showed a higher incidence of slow eoroany flow than non-smoker patients ( P = 0. 010). The blood levels of ET-1 ( 108.42 ± 0. 81 pg/mL vs84.74 ±39.16 pg/mL, P =0.001) and IL-6 (158.28 ± 178.86 pg/mL vs 108.07 ±84.43 pg/mL,P =0. 019) was higher in the slow flow group but with a lower levels of NO (35.66 ± 12. 28 μmol/l, vs 42. 74 ± 17.51 μmol/L, P = 0. 032 ) when compare with the nomal coronary folw group. Conclusion Slow coronary flow is related to endothelium disorder but other risk factors should also be taken into consideration.
出处 《中国介入心脏病学杂志》 2009年第6期332-334,共3页 Chinese Journal of Interventional Cardiology
基金 内蒙古自治区自然科学基金项目(200711020925)
关键词 冠状血管 血流速度 内皮 Coronary vessels Blood flow velocity Endothelium
  • 相关文献

参考文献6

  • 1Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantilative method of assessing coronary artery flow. Circulation, 1996,93 : 879-888.
  • 2Sezgin N, Baruteu I, Sozgin AT, et al. Plasma Nitric Oxide level and its role in slow coronary flow phenomenon. Int Heart J, 2005, 46:373-382.
  • 3Cetebi H, Catakoglu AB, Kurtoglu H, et al. The relation between coronary flow rate, plasma endothelin-1 concentmtions, and clinical characteristics in patients with normal coronary arteries, Cardiovase Revase Med ,2008,9:144-148.
  • 4Selcuk MT, Selcuk H, Temizhan A, et al. Asymmetric dimethylarginine plesma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Antery Dis,2007,18:545-551.
  • 5Stone GW, Brodie BR, Griffin JJ, et al. For the PAMI Stent Pilot Trial Investigators. Prospective, muhicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol, 1998,31:23-30.
  • 6Bickel C, Rupprecht HJ, Maimaitiming A, et al. The superiority of TIMI frame count in detecting coronary flow changes after coronary stenting compared to TIMI flow classification. J Invas Cardiol, 2002,14 : 125-128.

同被引文献38

  • 1Mangieri E,Macchiarelli G,Ciavolella M,et al.Slow coronary flow:clinical and histopathological features in patients with othwise normal epicardial coronary arteries[J].Cathet Cardiovasc Diagn,1996,37(2):375-381.
  • 2Beltrame JF,Tumer SP,Leslie SL,et al.The angiographic and clinical benefits of mibefradil in the coronary slow phenomenon[J].J Am Coll Cardiol,2004,44(2):57-62.
  • 3Celermajer DS,Sorensen KE,Gooth VM,et al.Non invasive detction of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8828):1111-1115.
  • 4Araujo JA.Circulating microparticles from patients with coronary artery disease cause endothelial dysfunction response[J].Rev Esp Cardiol.2012,65(4):389-390.
  • 5Ari H,Ari S,Erdogan E,et al.The effects of endothelial dysfunction and inflammation on slow coronary flow[J].Turk Kardiyol Dern Ars,2010,38(5):327-333.
  • 6Anderson TJ,Ueheta A,Cerhard MD,et al.Close relation of endothelial function in the humen coronary and periphera circulations[J].J Am Coll Cardiol,1995,26(4):1235-1241.
  • 7Takase B,Ueheta A,Akima T,et al.Endothelium-dependent flow-mediated vasodilation of coronary and brachial arteries in suspected coronary artery disease[J].Am J Cardiol,1998,82(4):1535-1539.
  • 8Gunes Y,Gumrukcuoglu HA,Akdag S,et al.,Vascular endothelial function in patients with coronary slow flow and the effects of nebivolol[J].Arq Bras Cardiol,2011,97(4):275-280.
  • 9Sekiya M,Sato M,Funada J,et al.Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis[J].J Cardiovasc Pharmacol,2005,46(1):63-67.
  • 10Hashimoto M,Shinozuka K,Sasaki T,et al.Nicorandil-induced ATP release in endothelial cells of rat caudal artery is associated with increase in intracellular Ca(2+)[J].Eur J Pharmacol,2001,416(3):179-183.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部